Brittany Ramirez
Medical · Lafayette, LANPI 1184929234
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 55.5% of the total. 2025 is the largest year on record at $1,579, 4.7 times the $333 reported in 2021.
Across 164 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$314
- Pfizer$142
- AstraZeneca$123
- Gilead$97
- Takeda Pharmaceuticals U.S.A., Inc.$90
- plus $525 from 13 others
What the payments were for
- Food & beverage$2,86299%
- Education$401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 97 | $1,612 |
| Johnson & Johnson | 17 | $314 |
| Pfizer | 7 | $142 |
| AstraZeneca | 1 | $123 |
| Gilead | 4 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| Ardelyx, Inc. | 5 | $87 |
| Celltrion USA Inc. | 4 | $84 |
| Phathom Pharmaceuticals, Inc. | 6 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Intercept Pharmaceuticals, Inc. | 4 | $52 |
| Madrigal Pharmaceuticals | 2 | $42 |
| QOL Medical, LLC | 2 | $32 |
| Merck | 2 | $26 |
| Sanofi | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,902 in reported general payments places this provider in the 75th percentile of 253 medical providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 25 | $13,211 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 34 | $2,228 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 13 | $2,179 |
| Famotidine | 91 | $898 |
| Pantoprazole Sodium | 70 | $658 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 21 | $319 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 18 | $268 |
| Dicyclomine Hcl | 15 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,612 | $13,21125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 253 medical providers in Louisiana.
Other medical in Lafayette
- Thomas BriscoeLafayette$13K
- Celenia StanfordLafayette$7K
- Victoria PlaucheLafayette$6K
- Eric BullerLafayette$6K
- Mary CaseLafayette$6K
- Ashley ParichLafayette$3K
- Kristi RobertBaton Rouge$486K
- Vickie RiceBaton Rouge$19K
- Mary McFerrenShreveport$16K
- Rachel RhinehartJefferson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.